Finance

Lists
4015:TADAWUL
Jamjoom Pharmaceuticals Fctry Cmpny SJSC
SAR 114.80
+1.06%
(+1.20) 1D
Nov 4, 3:16:27 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4015...
Open
SAR 114.00
High
SAR 115.70
Low
SAR 112.20
Mkt. cap
8.04B
Avg. vol.
36.80K
Volume
64.76K
Dividend
3.66%
Quarterly dividend
SAR 1.05
Ex-dividend date
Aug 2, 2026
P/E ratio
16.72
52-wk high
SAR 163.70
52-wk low
SAR 112.20
EPS
SAR 6.87
Shares outstanding
29.31M
No. of employees
1K
Open
SAR 114.00
High
SAR 115.70
Low
SAR 112.20
Mkt. cap
8.04B
Avg. vol.
36.80K
Volume
64.76K
Dividend
3.66%
Quarterly dividend
SAR 1.05
Ex-dividend date
Aug 2, 2026
P/E ratio
16.72
52-wk high
SAR 163.70
52-wk low
SAR 112.20
EPS
SAR 6.87
Shares outstanding
29.31M
No. of employees
1K
News stories
From web sources and news partners
About Jamjoom Pharmaceuticals Fctry Cmpny SJSC
CEO-
Employees1.13K
Founded1994
Headquarters-
SectorPharmaceutical industry
Industry-
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
304.57M
481.38M
445.31M
354.66M
Cost of goods sold
121.19M
171.00M
151.66M
131.78M
Cost of revenue
121.19M
171.00M
151.66M
131.78M
Research and development expenses
10.86M
9.40M
10.94M
4.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110.53M
125.39M
139.66M
105.06M
Operating expense
111.72M
138.01M
147.65M
107.61M
Total operating expenses
232.91M
309.01M
299.32M
239.39M
Operating income
71.66M
172.38M
146.00M
115.27M
Other non operating income
-1.17M
-
-
1.11M
EBT including unusual items
76.91M
174.94M
146.22M
116.96M
EBT excluding unusual items
77.01M
174.94M
146.22M
116.96M
Income tax expense
8.84M
6.73M
8.59M
6.75M
Effective tax rate
11.49%
3.85%
5.87%
5.77%
Other operating expenses
-8.56M
3.22M
-2.95M
-1.62M
Net income
68.07M
168.21M
137.63M
110.21M
Net profit margin
22.35%
34.94%
30.91%
31.08%
Earnings per share
-
-
-
-
Interest and investment income
784.73K
2.32M
1.36M
-
Interest expense
-
-1.54M
-954.23K
-2.17M
Net interest expenses
784.73K
785.30K
408.85K
-2.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
82.25M
183.73M
157.44M
127.46M
Gain or loss from assets sale
8.39K
34.74K
1.30K
-570.00
Upcoming events
AI content may include mistakes. Learn more
Google apps